Court ruling would lift cloud of uncertainty
The U.S. Supreme Court did not hand down a ruling in the health care reform case Monday morning. The nine justices meet again Thursday, but most observers expect the decision to come June 25 or June 28.
Health Care
Articles
Veteran hospital exec Odle to retire from IU Health
Sam Odle, one of Indianapolis’ most prominent black business leaders, will be replaced on an interim basis by Jim Terwilliger while the hospital system conducts a national search for his successor.
NFP of NOTE: Crohn’s and Colitis Foundation, Indiana Chapter
Crohn’s and Colitis Foundation's mission is to cure Crohn's disease and ulcerative colitis, and improve the quality of life of children and adults affected by these diseases.
Little Red Door absorbs program of group that’s disbanding
Fishers-based Cancer-Free Lungs decided last year it was ready to shut down.
Benefits brokers gain ground without merging
While mergers and acquisitions have been rampant in central Indiana’s benefits-broker industry the past five years, a handful of brokers has grown the old-fashioned way—by adding clients.
Employers slow to act on health reform
Even though employers expect the U.S. Supreme Court to strike down at least some of the 2010 health reform law later this month, few are actually doing any contingency planning.
Orthopedic startups attracting big money
The Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more fuel into a fairly stagnant entrepreneurial sector.
Domestic-partner benefits proposal introduced
Health-care benefits would be offered to the domestic partners of Indianapolis city workers under a proposal introduced Monday night to the City-County Council.
WellPoint buying 1-800 Contacts for about $900M
The Indianapolis-based health insurer said 1-800 Contacts is attractive partly because it has bigger profit margins than its core insurance business, The Wall Street Journal reported.
Area company rolls out inventive wellness benefit
EMC Precision Machining in Sheridan will give each of its 93 employees a new bicycle Friday for exceeding company cost-cutting goals.
Mainstreet signs operator for new health care properties
A Cicero-based developer has signed a national senior-living company to operate four new properties it plans for Indiana.
Price hikes offset slower health care use
Newly available data from private health insurance plans show that price hikes by hospitals, doctors and drug companies have kept employer spending rising recently even as their employees and dependents have moderated their consumption of health care services.
Fort Wayne health IT firm looks to Indianapolis for talent
By the end of 2012, Medical Informatics Engineering anticipates that its six-person Indianapolis workforce will have doubled to 12, then to as many as 25 over the following year or so.
Physician buyouts bruising hospitals
As St. Vincent Health has nearly doubled the number of physicians it employs over the past two years, the losses on those practices have mounted. And the same thing is happening at all the major Indianapolis hospital systems, as all have spent the past four years aggressively acquiring physician practices.
FDA’s $6.4B drug review fee plan passes Senate
The U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.
Howard officials OK hospital merger with Community
The merger of Kokomo’s Howard Regional Health System into Indianapolis-based Community Health Network received final approval Tuesday night.
Good cholesterol may not lower heart risk, study suggests
Raising good cholesterol, a goal pursued by Eli Lilly and Co. as the next milestone in cardiac care, may not cut heart-attack risk, says a study that challenges the development of drugs that may someday generate billions of dollars in sales.
U.S. losing drug-research jobs to other countries
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
Lilly unlikely to gain from Plavix patent loss, analyst says
Indianapolis-based Eli Lilly and Co. and London-based AstraZeneca Plc aren't expected to have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co.’s Plavix after the drug loses U.S. patent protection Thursday.
WellPoint protestors harass Braly as political disclosure proposal fails
The proposal, which sought twice-yearly reports on all the health insurer’s donations used for political campaigns or lobbying, was overwhelmingly voted down by WellPoint shareholders.